Corning® Valor® Glass Vials

Over the past few decades, significant progress has been made in the biopharmaceutical industry with advancements in biological drugs, filling lines, and drug delivery systems. However, the glass vials used to contain these drug products have remained largely unchanged since the introduction of borosilicate glass vials over 100 years ago. Traditional borosilicate glass vials are susceptible to quality issues, such as cosmetic defects, vial damage and glass particles that are generated in fill-finish operations. Additionally, borosilicate glass can delaminate on the drug-contact surface. Issues like delamination, glass particles, and cracked containers have led to drug recalls and pose a threat to drug product sterility.